Lakefront Biotherapeutics NV (AMS:LKFT)

AMS:LKFT Revenue

Lakefront Biotherapeutics NV had revenue of 13.66M EUR in the quarter ending June 30, 2026, a decrease of -81.44%. This brings the company's total for the last twelve months to 1.03B, up 227.88% year-over-year. In the year 2025, Lakefront Biotherapeutics NV had annual revenue of 1.17B with 268.41% growth. That makes Lakefront Biotherapeutics NV the 7,166th largest company in the world by revenue and 48th in the Netherlands.

• Revenue (ttm): 1.03B
• Revenue Growth: +227.88%
• P/S Ratio: 1.87
• Revenue / Employee: 5.05M
• Employees: 196
• Market Cap: 1.86B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States of America 1.08B 97.2%
• Europe 31.10M 2.8%

Fiscal year ended Dec 31, 2025 See the full AMS:LKFT breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.17B	849.32M	268.41%
Dec 31, 2024	316.42M	29.43M	10.25%
Dec 31, 2023	287.00M	9.62M	3.47%
Dec 31, 2022	277.38M	-3.08M	-1.10%
Dec 31, 2021	280.46M	-249.81M	-47.11%
Dec 31, 2020	530.26M	-355.54M	-40.14%
Dec 31, 2019	885.80M	578.13M	187.91%
Dec 31, 2018	307.67M	151.75M	97.33%
Dec 31, 2017	155.92M	4.31M	2.84%
Dec 31, 2016	151.61M	91.03M	150.27%
Dec 31, 2015	60.58M	-29.44M	-32.70%
Dec 31, 2014	90.02M	-6.55M	-6.78%
Dec 31, 2013	96.57M	4.35M	4.71%
Dec 31, 2012	92.23M	-23.06M	-20.01%
Dec 31, 2011	115.29M	-21.27M	-15.57%
Dec 31, 2010	136.56M	129.50M	1,835.39%
Dec 31, 2009	7.06M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error